Press releases
Prime Therapeutics increases COVID-19 vaccine administration reimbursement rates to pharmacies beyond Medicare mandate
Pharmacies serving commercial and health insurance marketplace members will also be paid at the new CMS rate
March 25, 2021EAGAN, Minn. – Pharmacies will soon be paid more to administer COVID-19 vaccinations, thanks to new, higher Medicare reimbursement rates recently set by the Centers for Medicare & Medicaid Services (CMS). Prime Therapeutics (Prime) and its Blue Plan clients took the CMS decision a step further and applied the higher rates to their Commercial and health insurance marketplace (HIM) lines of business as well.
Last week, the CMS increased reimbursement rates for administering COVID-19 vaccines to Medicare members to $40 for a single dose of any COVID-19 vaccine and $80 for a two-dose vaccine. Previously, reimbursement rates were $28.39 for a single-dose vaccine and $45.33 for a two-dose vaccine. Medicaid administration fees continue to be determined by each state. Prime will adjust the Medicaid reimbursement rates according to any revised guidance it receives from our Blue Plan clients. The CMS did not mandate the increase in other lines of business, but instead offered guidance to “consider prevailing market rates” for vaccine administration.
“Prime greatly values the role pharmacies are playing to help quickly deliver life-saving COVID-19 vaccines to millions of people across the country during this public health emergency,” said David Lassen, chief clinical officer at Prime. “These are extraordinary times, and this increase in reimbursement rates is the right thing to do to make sure our members have no barriers to access.”
Related news
Press releases
April 11, 2024
Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting
Press releases
March 13, 2024
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Strategic alliance allows Prime to offer exclusive access to Capital Rx’s leading technology platform to achieve a higher standard of care, increase efficiency, improve experiences and provide the foundation for the next generation of integrated pharmacy care for the more than 50 million Americans served by Prime
Press releases
February 8, 2024
Magellan Rx Management, LLC earns URAC Accreditation in Health Utilization Management
Designation demonstrates highest level of commitment to quality health care